The randomized controlled trial about the regression of atherosclerosis by using pioglitazone added to statin [HMG-CoA reductase inhibitors] treatment
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2008
At a glance
- Drugs Pioglitazone (Primary)
- Indications Atherosclerosis; Coronary artery disease
- Focus Therapeutic Use
- 02 Oct 2006 New trial record.